CD抗原

选项
视图 列表 网格

显示第112个,产品总数42

设置降序方向
  1. Recombinant Human Siglec-2/CD22 Protein
    • 种属: 人(Human)
    • Accession #: P20273
    • 表达系统: HEK293
    • 蛋白标签: C-His
    • 内毒素水平: <1.0 EU/μg
    • 生物活性: Immobilized Recombinant Human Siglec-2/CD22 Protein (rp169575) at 1.0 μg/mL can bind Inotuzumab (anti-CD22) (Ab176429) with the EC50 of 20.1 ng/mL.  Immobilized Recombinant Human Siglec-2/CD22 Protein (rp169575) at 1.0 μg/mL can bind bind Epratuzumab (anti-CD22) (Ab175532) with the EC50 of 207.0 ng/mL.
  2. Recombinant Human CD79B Protein
    • 种属: 人(Human)
    • Accession #: P40259
    • 表达系统: HEK293
    • 蛋白标签: C-His
    • 内毒素水平: <1.0 EU/μg
    • 生物活性: 1. Immobilized Recombinant Human CD79B Protein (rp176729) at 1.0 μg/mL can bind Polatuzumab (anti-CD79b) (Ab175715) with the EC50 of 11.08 ng/mL. 2. Immobilized Recombinant Human CD79B Protein (rp176729) at 1.0 μg/mL can bind Polatuzumab vedotin-piiq (anti-CD79b) (Ab175635) with the EC50 of 51.95 ng/mL.
  3. Recombinant Mouse NKp46/NCR1 Protein
    • 种属: 小鼠(Mouse)
    • Accession #: Q8C567
    • 表达系统: HEK293
    • 蛋白标签: C-hFc & His
    • 内毒素水平: <0.1 EU/μg
    • 生物活性: Measured by its binding ability in a functional ELISA. When Recombinant Mouse NKp46/NCR1 Fc Chimera is immobilized at 0.5 μg/mL (100 μL/well), the concentration of Recombinant Human Vimentin that produces 50% of the optimal binding response is found to be approximately 30-150 ng/mL.
每页